相关实验视频
Updated: Sep 16, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.7K
针对TP53TG1:一个有前途的预后生物标志物和个性化癌症治疗的治疗点
Haodong He1,2
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443002, China. 2636095835@qq.com.
Discover oncology
|July 7, 2025
概括
瘤蛋白p53点基因1 (TP53TG1),一个长的非编码RNA,在癌症中具有双重作用. 基于TP53TG1的癌症疗法,先进的输送系统显示出有前途.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- TP53TG1是染色体7q21.12.12上的一个长非编码RNA (lncRNA).
- 它既作为瘤基因,又作为瘤抑制剂,在各种癌症中表达失调.
- TP53TG1通过竞争性RNA活性,miRNA结合,信号通路和表观遗传修饰来影响基因表达.
研究的目的:
- 在10种癌症中审查TP53TG1的表达模式.
- 阐明其生物相关性和治疗潜力.
- 探索其临床应用和针对性交付的挑战.
主要方法:
- 关于TP53TG1在癌症中的作用的文献综述.
- 在10个恶性瘤中分析TP53TG1表达.
- 对TP53TG1疗法的RNA传递技术的评估.
主要成果:
- TP53TG1影响瘤的扩散,迁移,入侵,亡,治疗耐药性和瘤的免疫微环境.
- 像LNP这样的先进的传递系统显示了基于TP53TG1的疗法的潜力.
- TP53TG1为侵袭性和耐药性癌症提供治疗途径.
结论:
- 在瘤学中,TP53TG1是一个重要的分子标.
- 克服交付挑战对于临床翻译至关重要.
- 将TP53TG1与传统疗法相结合可能会改善患者的治疗结果.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K

